WEDNESDAY, Nov. 30, 2022 (HealthDay News) — The experimental Alzheimer’s drug lecanemab slowed thinking declines among patients suffering the early stages of the disease in a new study, but safety concerns about brain swelling and brain bleeds remain. In the eagerly awaited trial findings, published Tuesday in the New EnglandContinue Reading

TUESDAY, Nov. 29, 2022 (HealthDay News) — Two people have now died from brain hemorrhages that may be linked to an experimental Alzheimer’s drug, calling into question the medication’s safety. A 65-year-old woman with early-stage Alzheimer’s recently died from a massive brain bleed that some researchers link to lecanemab, anContinue Reading

TUESDAY, Nov. 22, 2022 (HealthDay News) — The genetic abnormality that drives Down syndrome causes the same sort of abnormal brain plaques and protein tangles that are found in Alzheimer’s disease patients, a new study reports. Amyloid beta plaques and tau tangles have long been associated with Alzheimer’s disease, andContinue Reading

SUNDAY, Nov. 13, 2022 (HealthDay News) — While most homes aren’t designed to be dementia-friendly, they can easily be adapted, according to a national Alzheimer’s disease group. “Virtually every aspect of a home can affect the person’s quality of life,” said Charles Fuschillo Jr., president and CEO of the Alzheimer’sContinue Reading

FRIDAY, Nov. 4, 2022 (HealthDay News) — A new study has shown the blood pressure drug telmisartan may offer new hope as an Alzheimer’s treatment in Black patients. It did not show the same benefit in white people. Learning how people from different ethnic groups respond to the same drugContinue Reading

TUESDAY, Nov. 1, 2022 (HealthDay News) – Early detection of memory issues is important. It can help rule in or out a variety of health issues, including vitamin deficiency, thyroid condition, sleep apnea, urinary tract infection and, of course, Alzheimer’s disease and related dementias. The Alzheimer’s Foundation of America suggestsContinue Reading

MONDAY, Oct. 10, 2022 (HealthDay News) – Women are diagnosed with Alzheimer’s disease twice as often as men. Now researchers think they know why. A new study found evidence in mice and human brain tissue that may explain the differences, according to researchers from Case Western University in Cleveland. FemaleContinue Reading